{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:13:33Z","timestamp":1787022813277,"version":"build-2736575974"},"reference-count":91,"publisher":"Bioscientifica","issue":"1","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"vor","delay-in-days":772,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Current models for the study of neuroendocrine tumours (NETs) are severely limited. While in vitro (e.g. cell lines), ex vivo (e.g. organoids) and in vivo (e.g. mice) models all exist, each has limitations. To address these limitations and collectively identify strategies to move the NET models field forward, we held an inaugural NET models meeting, hosted by our founding group: Dr Lines (Oxford), Prof. Quelle (Iowa), Dr Dayton (Barcelona), Dr Ear (Iowa), Dr Marinoni (Bern) and Dr Guenter (Alabama). This two-day meeting in Oxford (UK) was organised and supported by Bioscientifica Ltd and was solely dedicated to the discussion of NET models. The meeting was attended by \u223c30 international researchers (from the UK, EU, Israel, USA and Canada). Plenary talks were given by Prof. Thakker, who summarised NET research over the past few decades, and Dr Schrader, who described the process and pitfalls of generating new cell lines. Eight researchers also presented their work on topics ranging from human cell 3D bioprinting to zebrafish models and included novel ideas and improvements on current concepts. This was followed by an interactive workshop, where discussion topics included a summary of currently available NET models, limitations of these models, barriers to developing new models, and how we can address these issues going forward. This white paper summarises the key points raised in these discussions and the future aspirations of the NET Models Consortium. The next meeting will take place in Oxford (UK) in 2025; contact contact@netcancerfoundation.com for more information.<\/jats:p>","DOI":"10.1530\/eo-24-0055","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T07:45:21Z","timestamp":1732002321000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-15","source":"Crossref","is-referenced-by-count":6,"title":["NET Models Meeting 2024 white paper: the current state of neuroendocrine tumour research models and our future aspirations"],"prefix":"10.1530","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0823-9166","authenticated-orcid":true,"given":"Po Hien","family":"Ear","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Iowa 1 , , ,","place":["Iowa City, Iowa, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Marinoni","sequence":"additional","affiliation":[{"name":"Institute of Tissue Medicine and Pathology, University of Bern 2 , ,","place":["Bern, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talya","family":"Dayton","sequence":"additional","affiliation":[{"name":"European Molecular Biology Laboratory (EMBL) Barcelona, Tissue Biology and Disease Modelling 3 , ,","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1024-7037","authenticated-orcid":true,"given":"Rachael","family":"Guenter","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, University of Alabama at Birmingham 4 , , ,","place":["Birmingham, Alabama, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn E","family":"Quelle","sequence":"additional","affiliation":[{"name":"Department of Neuroscience and Pharmacology, University of Iowa 5 , , ,","place":["Iowa City, Iowa, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Battistella","sequence":"additional","affiliation":[{"name":"Pancreatic Surgery Unit, Pancreas Translational and Clinical Research Center, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University 6 , ,","place":["Milan, Italy"]},{"name":"Malignant B Cells Biology and 3D Modelling Unit, Experimental Oncology Department, Vita-Salute San Raffaele University 7 , ,","place":["Milan, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floryne O","family":"Buishand","sequence":"additional","affiliation":[{"name":"Department of Clinical Science and Services, Royal Veterinary College 8 , ,","place":["Hatfield, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suganthi","family":"Chittaranjan","sequence":"additional","affiliation":[{"name":"Department of Genome Sciences Centre, BC Cancer 9 , , ,","place":["Vancouver, British Columbia, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Cheih","family":"Nancy Du","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medicine 10 , , ,","place":["New York, New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Marques","sequence":"additional","affiliation":[{"name":"Institute of Anatomy, University of Bern 11 , ,","place":["Bern, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia S","family":"Pellegata","sequence":"additional","affiliation":[{"name":"Department of Biology and Biotechnology, University of Pavia 12 , ,","place":["Pavia, Italy"]},{"name":"Institute for Diabetes and Cancer, Helmholtz Munich 13 , ,","place":["Munich, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7538-9431","authenticated-orcid":true,"given":"Samira M","family":"Sadowski","sequence":"additional","affiliation":[{"name":"Endocrine Surgery Section, Surgical Oncology Program, Center for Cancer Research, NCI, NIH 14 , , ,","place":["Bethesda, Maryland, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3794-9634","authenticated-orcid":true,"given":"Amit","family":"Tirosh","sequence":"additional","affiliation":[{"name":"ENTIRE \u2013 Endocrine Neoplasia Translational Research Center, Sheba Medical Center, and Tel Aviv University Faculty of Medicine 15 , ,","place":["Tel Aviv, Israel"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"April-Monn","sequence":"additional","affiliation":[{"name":"Department of Pathology and Molecular Pathology, University Hospital Zurich 16 , ,","place":["Zurich, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Aurilia","sequence":"additional","affiliation":[{"name":"Associazione Italiana Neoplasie Endocrine Multiple di tipo 1 e di tipo 2 (AIMEN 1 e 2) 17 , ,","place":["Sondrio, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Jaskula-Sztul","sequence":"additional","affiliation":[{"name":"Department of Surgery, School of Medicine, University of Alabama at Birmingham 4 , , ,","place":["Birmingham, Alabama, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jes\u00fas","family":"Baena Moreno","sequence":"additional","affiliation":[{"name":"Center of Experimental Oncology, Gastrointestinal and Neuroendocrine Tumors Research Group, Research Institute Hospital 12 de Octubre (i+12) 18 , ,","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Donati","sequence":"additional","affiliation":[{"name":"Associazione Italiana Neoplasie Endocrine Multiple di tipo 1 e di tipo 2 (AIMEN 1 e 2) 17 , ,","place":["Sondrio, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1439-1834","authenticated-orcid":true,"given":"Katherine A","family":"English","sequence":"additional","affiliation":[{"name":"OCDEM, Radcliffe Department of Medicine, University of Oxford, Churchill Hospital 19 , ,","place":["Oxford, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2543-5038","authenticated-orcid":true,"given":"Maria Almudena","family":"Hernandez Llorens","sequence":"additional","affiliation":[{"name":"Center of Experimental Oncology, Gastrointestinal and Neuroendocrine Tumors Research Group, Research Institute Hospital 12 de Octubre (i+12) 18 , ,","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9498-1961","authenticated-orcid":true,"given":"Harry","family":"Hodgetts","sequence":"additional","affiliation":[{"name":"Regenerative Medicine and Fibrosis Group, Institute for Liver and Digestive Health, University College London, Royal Free Campus 20 , ,","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Marini","sequence":"additional","affiliation":[{"name":"FIRMO Foundation (Italian Foundation for the Research on Bone Diseases) 21 , ,","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Martins","sequence":"additional","affiliation":[{"name":"Regenerative Medicine and Fibrosis Group, Institute for Liver and Digestive Health, University College London, Royal Free Campus 20 , ,","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Palmini","sequence":"additional","affiliation":[{"name":"FIRMO Foundation (Italian Foundation for the Research on Bone Diseases) 21 , ,","place":["Florence, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1118-1316","authenticated-orcid":true,"given":"Beatriz","family":"Soldevilla","sequence":"additional","affiliation":[{"name":"Center of Experimental Oncology, Gastrointestinal and Neuroendocrine Tumors Research Group, Research Institute Hospital 12 de Octubre (i+12) 18 , ,","place":["Madrid, Spain"]},{"name":"Department of Genetics, Physiology and Microbiology, Faculty of Biology, Universidad Complutense de Madrid (UCM) 22 ,","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Schrader","sequence":"additional","affiliation":[{"name":"Department of Medicine, University Medical Center Hamburg-Eppendorf 23 , ,","place":["Hamburg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh V","family":"Thakker","sequence":"additional","affiliation":[{"name":"OCDEM, Radcliffe Department of Medicine, University of Oxford, Churchill Hospital 19 , ,","place":["Oxford, UK"]},{"name":"Oxford NIHR Biomedical Research Centre, Oxford University Hospitals Trust 24 , ,","place":["Oxford, UK"]},{"name":"Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London 25 , ,","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0764-8681","authenticated-orcid":true,"given":"Kate E","family":"Lines","sequence":"additional","affiliation":[{"name":"OCDEM, Radcliffe Department of Medicine, University of Oxford, Churchill Hospital 19 , ,","place":["Oxford, UK"]},{"name":"School of Biological and Medical Sciences, Faculty of Health and Life Sciences, Oxford Brookes University 26 , ,","place":["Oxford, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"2026070711072966200_bib1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1159\/000528539","article-title":"Cancer-associated fibroblasts induce proliferation and therapeutic resistance to everolimus in neuroendocrine tumors through STAT3 activation","volume":"113","author":"Amin","year":"2023","journal-title":"Neuroendocrinology"},{"key":"2026070711072966200_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000507669","article-title":"Three-dimensional primary cell culture: a novel preclinical model for pancreatic neuroendocrine tumors","volume":"111","author":"April-Monn","year":"2021","journal-title":"Neuroendocrinology"},{"key":"2026070711072966200_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41698-024-00549-2","article-title":"Patient derived tumoroids of high grade neuroendocrine neoplasms for more personalized therapies","volume":"8","author":"April-Monn","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"2026070711072966200_bib4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1158\/1541-7786.MCR-17-0163","article-title":"Establishment of the first well-differentiated human pancreatic neuroendocrine tumor model","volume":"16","author":"Benten","year":"2018","journal-title":"Mol Cancer Res"},{"key":"2026070711072966200_bib5","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1210\/me.2003-0154","article-title":"Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1","volume":"17","author":"Bertolino","year":"2003","journal-title":"Mol Endocrinol"},{"key":"2026070711072966200_bib6","doi-asserted-by":"crossref","first-page":"4856","DOI":"10.1158\/1078-0432.CCR-14-3036","article-title":"Nintedanib is a highly effective therapeutic for neuroendocrine carcinoma of the pancreas (PNET) in the Rip1Tag2 transgenic mouse model","volume":"21","author":"Bill","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2026070711072966200_bib7","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/s41556-019-0360-z","article-title":"Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening","volume":"21","author":"Boretto","year":"2019","journal-title":"Nat Cell Biol"},{"key":"2026070711072966200_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.21037\/apc.2019.06.02","article-title":"Insights into the biology and treatment strategies of pancreatic neuroendocrine tumors","volume":"2","author":"Buicko","year":"2019","journal-title":"Ann Pancreat Cancer"},{"key":"2026070711072966200_bib9","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1073\/pnas.48.7.1184","article-title":"Hormone-producing cultures of adrenal and pituitary tumor origin","volume":"48","author":"Buonassisi","year":"1962","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070711072966200_bib10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N Engl J Med"},{"key":"2026070711072966200_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1530\/ERC-17-0415","article-title":"Notch pathway inhibition targets chemoresistant insulinoma cancer stem cells","volume":"25","author":"Capodanno","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"2026070711072966200_bib12","doi-asserted-by":"crossref","first-page":"101269","DOI":"10.1016\/j.tranon.2021.101269","article-title":"Canine insulinoma as a model for human malignant insulinoma research: novel perspectives for translational clinical studies","volume":"15","author":"Capodanno","year":"2022","journal-title":"Transl Oncol"},{"key":"2026070711072966200_bib13","first-page":"2913","article-title":"Establishment and identification of small cell lung cancer cell lines having classic and variant features","volume":"45","author":"Carney","year":"1985","journal-title":"Cancer Res"},{"key":"2026070711072966200_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41389-021-00372-5","article-title":"Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors","volume":"10","author":"Carter","year":"2021","journal-title":"Oncogenesis"},{"key":"2026070711072966200_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1001\/jamaoncol.2019.4568","article-title":"Neuroendocrine tumors-less well known, often misunderstood, and rapidly growing in incidence","volume":"6","author":"Chauhan","year":"2020","journal-title":"JAMA Oncol"},{"key":"2026070711072966200_bib16","doi-asserted-by":"crossref","first-page":"10384","DOI":"10.1038\/ncomms10384","article-title":"Bcl-xL promotes metastasis independent of its anti-apoptotic activity","volume":"7","author":"Choi","year":"2016","journal-title":"Nat Commun"},{"key":"2026070711072966200_bib17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12943-019-1018-y","article-title":"Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression","volume":"18","author":"Choi","year":"2019","journal-title":"Mol Cancer"},{"key":"2026070711072966200_bib18","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling development and disease with organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"key":"2026070711072966200_bib19","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1073\/pnas.98.3.1118","article-title":"A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors","volume":"98","author":"Crabtree","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070711072966200_bib20","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1128\/MCB.23.17.6075-6085.2003","article-title":"Of mice and MEN1: insulinomas in a conditional mouse knockout","volume":"23","author":"Crabtree","year":"2003","journal-title":"Mol Cell Biol"},{"key":"2026070711072966200_bib21","doi-asserted-by":"crossref","first-page":"999792","DOI":"10.3389\/fendo.2023.999792","article-title":"Long-term organoid culture of a small intestinal neuroendocrine tumor","volume":"14","author":"D'Agosto","year":"2023","journal-title":"Front Endocrinol"},{"key":"2026070711072966200_bib22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11912-021-01029-7","article-title":"Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?","volume":"23","author":"Das","year":"2021","journal-title":"Curr Oncol Rep"},{"key":"2026070711072966200_bib23","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1016\/j.ccell.2023.11.007","article-title":"Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites","volume":"41","author":"Dayton","year":"2023","journal-title":"Cancer Cell"},{"key":"2026070711072966200_bib24","doi-asserted-by":"crossref","first-page":"R315","DOI":"10.1530\/ERC-17-0012","article-title":"Genetic and epigenetic drivers of neuroendocrine tumours (NET)","volume":"24","author":"Di Domenico","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"2026070711072966200_bib25","doi-asserted-by":"crossref","first-page":"e276","DOI":"10.1371\/journal.pbio.0050276","article-title":"Assessing tumor progression factors by somatic gene transfer into a mouse model: Bcl-xL promotes islet tumor cell invasion","volume":"5","author":"Du","year":"2007","journal-title":"PLoS Biol"},{"key":"2026070711072966200_bib26","doi-asserted-by":"crossref","first-page":"16753","DOI":"10.1073\/pnas.1114022108","article-title":"Receptor for hyaluronan-mediated motility isoform B promotes liver metastasis in a mouse model of multistep tumorigenesis and a tail vein assay for metastasis","volume":"108","author":"Du","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070711072966200_bib27","article-title":"Establishment and characterization of small bowel neuroendocrine tumor spheroids","volume":"152","author":"Ear","year":"2019","journal-title":"J Vis Exp"},{"key":"2026070711072966200_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0016-5085(91)90004-5","article-title":"Establishment and characterization of a human carcinoid in nude mice and effect of various agents on tumor growth","volume":"101","author":"Evers","year":"1991","journal-title":"Gastroenterology"},{"key":"2026070711072966200_bib29","doi-asserted-by":"crossref","first-page":"E8234","DOI":"10.1073\/pnas.1618389114","article-title":"Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts","volume":"114","author":"Fior","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070711072966200_bib30","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.3390\/cancers15153756","article-title":"Models in pancreatic neuroendocrine neoplasms: current perspectives and future directions","volume":"15","author":"Forsythe","year":"2023","journal-title":"Cancers"},{"key":"2026070711072966200_bib31","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2821","article-title":"Somatic mutation of CDKN1B in small intestine neuroendocrine tumors","volume":"45","author":"Francis","year":"2013","journal-title":"Nat Genet"},{"key":"2026070711072966200_bib32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/nrendo.2018.3","article-title":"Current and emerging therapies for PNETs in patients with or without MEN1","volume":"14","author":"Frost","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2026070711072966200_bib33","doi-asserted-by":"crossref","first-page":"8510","DOI":"10.1038\/s41598-024-58874-2","article-title":"Combined deletion of MEN1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice","volume":"14","author":"Fuentes","year":"2024","journal-title":"Sci Rep"},{"key":"2026070711072966200_bib34","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.stem.2016.04.003","article-title":"A colorectal tumor organoid library demonstrates progressive loss of niche factor requirements during tumorigenesis","volume":"18","author":"Fujii","year":"2016","journal-title":"Cell Stem Cell"},{"key":"2026070711072966200_bib35","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/ph17030334","article-title":"Towards effective targeted alpha therapy for neuroendocrine tumours: a review","volume":"17","author":"Gape","year":"2024","journal-title":"Pharmaceuticals"},{"key":"2026070711072966200_bib36","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3390\/cancers13081873","article-title":"Autofluorescence imaging of treatment response in neuroendocrine tumor organoids","volume":"13","author":"Gillette","year":"2021","journal-title":"Cancers"},{"key":"2026070711072966200_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J Gen Virol"},{"key":"2026070711072966200_bib38","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1073\/pnas.73.7.2424","article-title":"Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor","volume":"73","author":"Greene","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070711072966200_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/315115a0","article-title":"Heritable formation of pancreatic \u03b2-cell tumours in transgenic mice expressing recombinant insulin\/simian virus 40 oncogenes","volume":"315","author":"Hanahan","year":"1985","journal-title":"Nature"},{"key":"2026070711072966200_bib40","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1016\/S0959-8049(96)00401-7","article-title":"Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models","volume":"32","author":"Hanahan","year":"1996","journal-title":"Eur J Cancer"},{"key":"2026070711072966200_bib41","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1677\/ERC-09-0082","article-title":"Multiple endocrine neoplasia type 1 knockout mice develop parathyroid, pancreatic, pituitary and adrenal tumours with hypercalcaemia, hypophosphataemia and hypercorticosteronaemia","volume":"16","author":"Harding","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"2026070711072966200_bib42","doi-asserted-by":"crossref","first-page":"710009","DOI":"10.3389\/fendo.2021.710009","article-title":"Ex vivo modeling of human neuroendocrine tumors in tissue surrogates","volume":"12","author":"Herring","year":"2021","journal-title":"Front Endocrinol"},{"key":"2026070711072966200_bib43","doi-asserted-by":"crossref","first-page":"X1","DOI":"10.1530\/ERC-17-0445e","article-title":"The neuroendocrine phenotype, genomic profile and therapeutic sensitivity of GEPNET cell lines","volume":"25","author":"Hofving","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"2026070711072966200_bib44","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.1200609","article-title":"DAXX\/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors","volume":"331","author":"Jiao","year":"2011","journal-title":"Science"},{"key":"2026070711072966200_bib45","first-page":"596","article-title":"Establishment of a carcinoembryonic antigen-producing cell line from human pancreatic carcinoma","volume":"71","author":"Kaku","year":"1980","journal-title":"Gan"},{"key":"2026070711072966200_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1055\/a-2204-4549","article-title":"Animal and cell culture models of PPGLs \u2013 achievements and limitations","volume":"56","author":"Karna","year":"2024","journal-title":"Horm Metab Res"},{"key":"2026070711072966200_bib47","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.cell.2020.10.023","article-title":"An organoid biobank of neuroendocrine neoplasms enables genotype-phenotype mapping","volume":"183","author":"Kawasaki","year":"2020","journal-title":"Cell"},{"key":"2026070711072966200_bib48","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0002-9440(10)64017-5","article-title":"A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake","volume":"158","author":"K\u00f6lby","year":"2001","journal-title":"Am J Pathol"},{"key":"2026070711072966200_bib49","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","article-title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","volume":"25","author":"Kopper","year":"2019","journal-title":"Nat Med"},{"key":"2026070711072966200_bib50","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00401-013-1132-7","article-title":"Transcriptome analysis of MENX-associated rat pituitary adenomas identifies novel molecular mechanisms involved in the pathogenesis of human pituitary gonadotroph adenomas","volume":"126","author":"Lee","year":"2013","journal-title":"Acta Neuropathol"},{"key":"2026070711072966200_bib51","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00259-023-06494-9","article-title":"Structural modifications toward improved lead-203\/lead-212 peptide-based image-guided alpha-particle radiopharmaceutical therapies for neuroendocrine tumors","volume":"51","author":"Lee","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026070711072966200_bib52","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mce.2015.08.024","article-title":"Animal models of pituitary neoplasia","volume":"421","author":"Lines","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"2026070711072966200_bib53","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1530\/EC-17-0040","article-title":"A MEN1 pancreatic neuroendocrine tumour mouse model under temporal control","volume":"6","author":"Lines","year":"2017","journal-title":"Endocr Connect"},{"key":"2026070711072966200_bib54","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ijc.22288","article-title":"Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1","volume":"120","author":"Loffler","year":"2007","journal-title":"Int J Cancer"},{"key":"2026070711072966200_bib55","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s13577-022-00696-3","article-title":"Establishment and characterization of the third non-functional human pancreatic neuroendocrine tumor cell line","volume":"35","author":"Lou","year":"2022","journal-title":"Hum Cell"},{"key":"2026070711072966200_bib56","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/cancers12030691","article-title":"A comprehensive molecular characterization of the pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1","volume":"12","author":"Luley","year":"2020","journal-title":"Cancers"},{"key":"2026070711072966200_bib57","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.3390\/cancers13205117","article-title":"Pancreatic neuroendocrine tumors: molecular mechanisms and therapeutic targets","volume":"13","author":"Maharjan","year":"2021","journal-title":"Cancers"},{"key":"2026070711072966200_bib58","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2407-9-128","article-title":"Metastatic behaviour of primary human tumours in a zebrafish xenotransplantation model","volume":"9","author":"Marques","year":"2009","journal-title":"BMC Cancer"},{"key":"2026070711072966200_bib59","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1210\/endo-127-1-126","article-title":"Establishment of a pancreatic \u03b2 cell line that retains glucose-inducible insulin secretion: special reference to expression of glucose transporter isoforms","volume":"127","author":"Miyazaki","year":"1990","journal-title":"Endocrinology"},{"key":"2026070711072966200_bib60","doi-asserted-by":"crossref","first-page":"18493","DOI":"10.1073\/pnas.1003956107","article-title":"Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma","volume":"107","author":"Molatore","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070711072966200_bib61","doi-asserted-by":"crossref","first-page":"14572","DOI":"10.1038\/s41598-020-71516-7","article-title":"Generation and characterization of CRISPR\/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line","volume":"10","author":"Monazzam","year":"2020","journal-title":"Sci Rep"},{"key":"2026070711072966200_bib62","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.soc.2019.11.002","article-title":"Evolution of neuroendocrine tumor therapy","volume":"29","author":"O'Dorisio","year":"2020","journal-title":"Surg Oncol Clin N Am"},{"key":"2026070711072966200_bib63","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0603877103","article-title":"Germ-line mutations in p27 Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans","volume":"103","author":"Pellegata","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070711072966200_bib64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00335-003-3027-8","article-title":"Mapping of a novel MEN-like syndrome locus to rat chromosome 4","volume":"15","author":"Piotrowska","year":"2004","journal-title":"Mamm Genome"},{"key":"2026070711072966200_bib65","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1073\/pnas.41.7.432","article-title":"A rapid method for viable cell titration and clone production with hela cells in tissue culture: the use of X-irradiated cells to supply conditioning factors","volume":"41","author":"Puck","year":"1955","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026070711072966200_bib66","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJMoa1003825","article-title":"Sunitinib malate for the treatment of pancreatic neuroendocrine tumors","volume":"364","author":"Raymond","year":"2011","journal-title":"N Engl J Med"},{"key":"2026070711072966200_bib67","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1002\/ijc.30400","article-title":"The epidemiology of metastases in neuroendocrine tumors","volume":"139","author":"Riihim\u00e4ki","year":"2016","journal-title":"Int J Cancer"},{"key":"2026070711072966200_bib68","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","article-title":"A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal","volume":"31","author":"Rindi","year":"2018","journal-title":"Mod Pathol"},{"key":"2026070711072966200_bib69","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group","volume":"27","author":"Rinke","year":"2009","journal-title":"J Clin Oncol"},{"key":"2026070711072966200_bib70","first-page":"39","article-title":"The role of surgery and transplantation in neuroendocrine tumours","volume":"72","author":"Roeyen","year":"2009","journal-title":"Acta Gastroenterol Belg"},{"key":"2026070711072966200_bib71","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"key":"2026070711072966200_bib72","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.3390\/cancers14225646","article-title":"Preclinical models of neuroendocrine neoplasia","volume":"14","author":"Sedlack","year":"2022","journal-title":"Cancers"},{"key":"2026070711072966200_bib73","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1016\/S0140-6736(24)00701-3","article-title":"[(177)Lu]Lu-DOTA-TATE plus long-acting octreotide versus high-dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2-3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study","volume":"403","author":"Singh","year":"2024","journal-title":"Lancet"},{"key":"2026070711072966200_bib74","doi-asserted-by":"crossref","first-page":"105","DOI":"10.14573\/altex.2010.2.105","article-title":"Pancreatic beta cell lines and their applications in diabetes mellitus research","volume":"27","author":"Skelin","year":"2010","journal-title":"Altex"},{"key":"2026070711072966200_bib75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of (177)Lu-dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N Engl J Med"},{"key":"2026070711072966200_bib76","doi-asserted-by":"crossref","first-page":"dmm049552","DOI":"10.1242\/dmm.049552","article-title":"Context matters - Daxx and Atrx are not robust tumor suppressors in the murine endocrine pancreas","volume":"15","author":"Sun","year":"2022","journal-title":"Dis Model Mech"},{"key":"2026070711072966200_bib77","doi-asserted-by":"crossref","first-page":"bvad114.2115","DOI":"10.1210\/jendso\/bvad114.2115","article-title":"THU487 xenograft of VHL-deficient pancreatic neuroendocrine neoplasm cells \u2013 a novel low-grade PNEN in vivo model","volume":"7","author":"Telerman","year":"2023","journal-title":"J Endocr Soc"},{"key":"2026070711072966200_bib78","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/00006676-200101000-00016","article-title":"Isolation, maintenance, and characterization of human pancreatic islet tumor cells expressing vasoactive intestinal peptide","volume":"22","author":"Tillotson","year":"2001","journal-title":"Pancreas"},{"key":"2026070711072966200_bib79","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3390\/cancers14081910","article-title":"Establishment of novel neuroendocrine carcinoma patient-derived xenograft models for receptor peptide-targeted therapy","volume":"14","author":"Tran","year":"2022","journal-title":"Cancers"},{"key":"2026070711072966200_bib80","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1038\/s41467-021-24812-3","article-title":"The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets","volume":"12","author":"van Riet","year":"2021","journal-title":"Nat Commun"},{"key":"2026070711072966200_bib81","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1530\/JME-14-0304","article-title":"Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1","volume":"54","author":"Vandamme","year":"2015","journal-title":"J Mol Endocrinol"},{"key":"2026070711072966200_bib82","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s13402-022-00727-z","article-title":"Novel preclinical gastroenteropancreatic neuroendocrine neoplasia models demonstrate the feasibility of mutation-based targeted therapy","volume":"45","author":"Viol","year":"2022","journal-title":"Cell Oncol"},{"key":"2026070711072966200_bib83","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/ERC-13-0388","article-title":"Zebrafish as an innovative model for neuroendocrine tumors","volume":"21","author":"Vitale","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"2026070711072966200_bib84","doi-asserted-by":"crossref","first-page":"eaba8415","DOI":"10.1126\/sciadv.aba8415","article-title":"Daxx maintains endogenous retroviral silencing and restricts cellular plasticity in vivo","volume":"6","author":"Wasylishen","year":"2020","journal-title":"Sci Adv"},{"key":"2026070711072966200_bib85","doi-asserted-by":"crossref","first-page":"100510","DOI":"10.1016\/j.lanepe.2022.100510","article-title":"Incidence and survival of neuroendocrine neoplasia in England 1995\u20132018: a retrospective, population-based study","volume":"23","author":"White","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"2026070711072966200_bib87","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa1009290","article-title":"Everolimus for advanced pancreatic neuroendocrine tumors","volume":"364","author":"Yao","year":"2011","journal-title":"N Engl J Med"},{"key":"2026070711072966200_bib86","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/S0140-6736(15)00817-X","article-title":"Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study","volume":"387","author":"Yao","year":"2016","journal-title":"Lancet"},{"key":"2026070711072966200_bib88","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000486096","article-title":"The evolution of neuroendocrine tumor treatment reflected by ENETS guidelines","volume":"106","author":"Zandee","year":"2018","journal-title":"Neuroendocrinology"},{"key":"2026070711072966200_bib89","article-title":"Identification and characterization of metastatic factors by gene transfer into the novel RIP-tag; RIP-tva murine model","volume":"128","author":"Zhang","year":"2017","journal-title":"J Vis Exp"},{"key":"2026070711072966200_bib90","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ajpath.2019.11.007","article-title":"miR-431 promotes metastasis of pancreatic neuroendocrine tumors by targeting DAB2 interacting protein, a Ras GTPase activating protein tumor suppressor","volume":"190","author":"Zhang","year":"2020","journal-title":"Am J Pathol"},{"key":"2026070711072966200_bib91","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s11102-019-01003-4","article-title":"Common tools for pituitary adenomas research: cell lines and primary cells","volume":"23","author":"Zhu","year":"2020","journal-title":"Pituitary"}],"container-title":["Endocrine Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eo.bioscientifica.com\/view\/journals\/eo\/4\/1\/EO-24-0055.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eo.bioscientifica.com\/downloadpdf\/journals\/eo\/4\/1\/EO-24-0055.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/eo\/article-pdf\/doi\/10.1530\/EO-24-0055\/10874\/eo-24-0055.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/eo\/article-pdf\/doi\/10.1530\/EO-24-0055\/10874\/eo-24-0055.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:43:36Z","timestamp":1783439016000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/eo\/article\/4\/1\/e240055\/1576\/NET-Models-Meeting-2024-white-paper-the-current"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.1530\/eo-24-0055","relation":{},"ISSN":["2634-4793"],"issn-type":[{"value":"2634-4793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,1]]},"article-number":"e240055"}}